Predicting clinical remission in biologic-treated severe asthma: development of a practical scoring system from a Japanese multicentre study

Key Points

• The study aims to develop a practical scoring system to predict clinical remission in patients with severe asthma treated with biologics.
• Multicenter study conducted in Japan
• Development of the MAC score based on three key clinical metrics
• Integration of data from various healthcare settings
• The MAC score effectively predicts clinical remission across three domains
• Easily applicable in both primary care and tertiary hospital settings
• Demonstrated effectiveness with routinely accessible patient information